In another move to curb the spread of Covid-19 in the country, the government is currently negotiating to procure an anti-viral experimental drug.
This drug is hailed as a breakthrough for Covid-19 treatment after studies revealed that the pills can reduce deaths and hospitalisation rates by half.
— Reuters (@Reuters) October 1, 2021
Health Minister Khairy Jamaluddin recently said the pills were manufactured by US-based Merck & Co and uses molnupiravir which is designed to introduce errors into the genetic code of the virus.
“As we transition to living with Covid we will be adding new, innovative treatment options to our arsenal in addition to vaccines,” Khairy tweeted.
“I have already started negotiating for Malaysia to procure these effective drugs that have gone through clinical trials,” he added.
Khairy had previously said that public health authorities will now work towards living with Covid-19 as it expects the disease to be endemic, shifting away from the initial target of achieving herd immunity.
As of yesterday, a total 63.1 per cent of Malaysians had already been fully vaccinated, with the highest of 81.7 per cent recorded in the Klang Valley.
A total 87.6 per cent of the adult population has been fully vaccinated, while 3.5 per cent of those aged between 12 – 17-years have received both vaccine doses.